ENANTA PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ENANTA PHARMACEUTICALS, INC (ENTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.29 million shares for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 18.00K shares, a 10.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 120.00K shares, a 18.81% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 1.15M shares, a 8.67% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 20.00K shares, a 150.00% increase year-over-year.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.20M shares, a 11.94% decline from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.36M shares, a 78.43% increase from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 765.00K shares, a 14.43% decline from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 894.00K shares, a 0.78% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 18.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | 138.00K shares derived: sum of 2 quarters · filed 2026-08-12 | 1.29M shares 10-Q · filed 2026-08-12 | 1.31M shares derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | 120.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | 1.27M shares 10-Q · filed 2026-05-13 | 1.29M shares derived: sum of 3 quarters · filed 2026-05-13 | 1.31M shares derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-12-31 | 1.15M shares 10-Q · filed 2026-02-11 | 1.17M shares derived: sum of 2 quarters · filed 2026-02-11 | 1.19M shares derived: sum of 3 quarters · filed 2026-02-11 | 1.29M shares derived: sum of 4 quarters · filed 2026-02-11 | |
| 2025-09-30 | 20.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | 40.00K shares derived: sum of 2 quarters · filed 2025-11-19 | 141.00K shares derived: sum of 3 quarters · filed 2025-11-19 | 1.20M shares 10-K · filed 2025-11-19 | |
| 2025-06-30 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | 121.00K shares derived: sum of 2 quarters · filed 2025-08-13 | 1.18M shares 10-Q · filed 2025-08-13 | 1.19M shares derived: sum of 4 quarters · filed 2025-08-13 | |
| 2025-03-31 | 101.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | 1.16M shares 10-Q · filed 2025-05-14 | 1.17M shares derived: sum of 3 quarters · filed 2025-05-14 | 1.33M shares derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-12-31 | 1.06M shares 10-Q · filed 2025-02-12 | 1.07M shares derived: sum of 2 quarters · filed 2025-02-12 | 1.23M shares derived: sum of 3 quarters · filed 2025-02-12 | 1.33M shares derived: sum of 4 quarters · filed 2025-02-12 | |
| 2024-09-30 | 8.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | 169.00K shares derived: sum of 2 quarters · filed 2024-11-27 | 273.00K shares derived: sum of 3 quarters · filed 2024-11-27 | 1.36M shares 10-K · filed 2024-11-27 | |
| 2024-06-30 | 161.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | 265.00K shares derived: sum of 2 quarters · filed 2024-08-07 | 1.36M shares 10-Q · filed 2024-08-07 | ||
| 2024-03-31 | 104.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | 1.20M shares 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | 1.09M shares 10-Q · filed 2024-02-08 | ||||
| 2023-09-30 | 765.00K shares 10-K · filed 2023-11-22 | ||||
| 2023-03-31 | 137.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 755.00K shares 10-Q · filed 2023-08-08 | 728.00K shares 10-Q · filed 2023-05-09 | 885.00K shares derived: sum of 3 quarters · filed 2023-08-08 | 936.00K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | 618.00K shares 10-Q · filed 2023-02-08 | 748.00K shares derived: sum of 2 quarters · filed 2023-02-08 | 799.00K shares derived: sum of 3 quarters · filed 2023-02-08 | 905.00K shares derived: sum of 4 quarters · filed 2023-02-08 | |
| 2022-09-30 | 130.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | 181.00K shares derived: sum of 2 quarters · filed 2022-11-23 | 287.00K shares derived: sum of 3 quarters · filed 2022-11-23 | 894.00K shares 10-K · filed 2022-11-23 | |
| 2022-06-30 | 51.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | 157.00K shares derived: sum of 2 quarters · filed 2022-08-08 | 764.00K shares 10-Q · filed 2022-08-08 | 810.00K shares derived: sum of 4 quarters · filed 2022-08-08 | |
| 2022-03-31 | 106.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09 | 713.00K shares 10-Q · filed 2022-05-09 | 759.00K shares derived: sum of 3 quarters · filed 2022-05-09 | 809.00K shares derived: sum of 4 quarters · filed 2022-05-09 | |
| 2021-12-31 | 607.00K shares 10-Q · filed 2022-02-10 | 653.00K shares derived: sum of 2 quarters · filed 2022-02-10 | 703.00K shares derived: sum of 3 quarters · filed 2022-02-10 | 889.00K shares derived: sum of 4 quarters · filed 2022-02-10 | |
| 2021-09-30 | 46.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | 96.00K shares derived: sum of 2 quarters · filed 2021-11-24 | 282.00K shares derived: sum of 3 quarters · filed 2021-11-24 | 901.00K shares 10-K · filed 2021-11-24 | |
| 2021-06-30 | 50.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 | 236.00K shares derived: sum of 2 quarters · filed 2021-08-09 | 855.00K shares 10-Q · filed 2021-08-09 | 911.00K shares derived: sum of 4 quarters · filed 2021-08-09 | |
| 2021-03-31 | 186.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10 | 805.00K shares 10-Q · filed 2021-05-10 | 861.00K shares derived: sum of 3 quarters · filed 2021-05-10 | 941.00K shares derived: sum of 4 quarters · filed 2021-05-10 | |
| 2020-12-31 | 619.00K shares 10-Q · filed 2021-02-09 | 675.00K shares derived: sum of 2 quarters · filed 2021-02-09 | 755.00K shares derived: sum of 3 quarters · filed 2021-02-09 | 862.00K shares derived: sum of 4 quarters · filed 2021-02-09 | |
| 2020-09-30 | 56.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | 136.00K shares derived: sum of 2 quarters · filed 2020-11-25 | 243.00K shares derived: sum of 3 quarters · filed 2020-11-25 | 820.00K shares 10-K · filed 2020-11-25 | |
| 2020-06-30 | 80.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10 | 187.00K shares derived: sum of 2 quarters · filed 2020-08-10 | 764.00K shares 10-Q · filed 2020-08-10 | 803.00K shares derived: sum of 4 quarters · filed 2020-08-10 | |
| 2020-03-31 | 107.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11 | 684.00K shares 10-Q · filed 2020-05-11 | 723.00K shares derived: sum of 3 quarters · filed 2020-05-11 | 800.00K shares derived: sum of 4 quarters · filed 2020-05-11 | |
| 2019-12-31 | 577.00K shares 10-Q · filed 2020-02-10 | 616.00K shares derived: sum of 2 quarters · filed 2020-02-10 | 693.00K shares derived: sum of 3 quarters · filed 2020-02-10 | 746.00K shares derived: sum of 4 quarters · filed 2020-02-10 | |
| 2019-09-30 | 39.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | 116.00K shares derived: sum of 2 quarters · filed 2019-11-27 | 169.00K shares derived: sum of 3 quarters · filed 2019-11-27 | 653.00K shares 10-K · filed 2019-11-27 | |
| 2019-06-30 | 77.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | 130.00K shares derived: sum of 2 quarters · filed 2019-08-09 | 614.00K shares 10-Q · filed 2019-08-09 | 635.00K shares derived: sum of 4 quarters · filed 2019-08-09 | |
| 2019-03-31 | 53.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | 537.00K shares 10-Q · filed 2019-05-10 | 558.00K shares derived: sum of 3 quarters · filed 2019-05-10 | 607.00K shares derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-12-31 | 484.00K shares 10-Q · filed 2019-02-08 | 505.00K shares derived: sum of 2 quarters · filed 2019-02-08 | 554.00K shares derived: sum of 3 quarters · filed 2019-02-08 | 624.00K shares derived: sum of 4 quarters · filed 2019-02-08 | |
| 2018-09-30 | 21.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | 70.00K shares derived: sum of 2 quarters · filed 2018-11-29 | 140.00K shares derived: sum of 3 quarters · filed 2018-11-29 | 606.00K shares 10-K · filed 2018-11-29 | |
| 2018-06-30 | 49.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | 119.00K shares derived: sum of 2 quarters · filed 2018-08-09 | 585.00K shares 10-Q · filed 2018-08-09 | 638.98K shares derived: sum of 4 quarters · filed 2018-08-09 | |
| 2018-03-31 | 70.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | 536.00K shares 10-Q · filed 2018-05-10 | 589.98K shares derived: sum of 3 quarters · filed 2018-05-10 | 607.38K shares derived: sum of 4 quarters · filed 2018-05-10 | |
| 2017-12-31 | 466.00K shares 10-Q · filed 2018-02-09 | 519.98K shares derived: sum of 2 quarters · filed 2018-02-09 | 537.38K shares derived: sum of 3 quarters · filed 2018-02-09 | 594.48K shares derived: sum of 4 quarters · filed 2018-02-09 | |
| 2017-09-30 | 53.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | 71.38K shares derived: sum of 2 quarters · filed 2017-12-11 | 128.48K shares derived: sum of 3 quarters · filed 2017-12-11 | 613.00K shares 10-K · filed 2017-12-11 | |
| 2017-06-30 | 17.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | 74.50K shares derived: sum of 2 quarters · filed 2017-08-09 | 559.02K shares 10-Q · filed 2017-08-09 | 572.92K shares derived: sum of 4 quarters · filed 2017-08-09 | |
| 2017-03-31 | 57.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | 541.62K shares 10-Q · filed 2017-05-10 | 555.52K shares derived: sum of 3 quarters · filed 2017-05-10 | 605.42K shares derived: sum of 4 quarters · filed 2017-05-10 | |
| 2016-12-31 | 484.52K shares 10-Q · filed 2017-02-09 | 498.42K shares derived: sum of 2 quarters · filed 2017-02-09 | 548.32K shares derived: sum of 3 quarters · filed 2017-02-09 | ||
| 2016-09-30 | 13.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | 63.80K shares derived: sum of 2 quarters · filed 2016-12-09 | 509.68K shares 10-K · filed 2016-12-09 | ||
| 2016-06-30 | 49.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | 495.78K shares 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | 445.88K shares 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |